Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Amgen
Kyowa Kirin Co., Ltd.
Valerio Therapeutics
Valerio Therapeutics
Theraclion
Amgen